Correction: Risk stratification for adjuvant radiotherapy in pathologic T3N0 rectal cancer using a DeepSurv-based survival model - Summary - MDSpire

Correction: Risk stratification for adjuvant radiotherapy in pathologic T3N0 rectal cancer using a DeepSurv-based survival model

  • By

  • Yunxia Huang

  • Yanzong Lin

  • Qingyang Zhuang

  • Xinyuan Wu

  • Qiping Fan

  • Junxin Wu

  • June 12, 2026

  • 0 min

Share

Objective:

To correct the omission of the funding source in the original article regarding risk stratification for adjuvant radiotherapy in pathologic T3N0 rectal cancer.

Key Findings:
  • The funding source 'Fujian Province Gastrointestinal, Respiratory, Genitourinary Malignant Tumor Radiotherapy Radiation and Treatment Clinical Medical Research Center (2021Y2014)' was erroneously omitted in the original article.
Interpretation:

Conclusion:

The article has been amended to include the correct funding source.

Sources:

Original Source(s)

Correction: Risk stratification for adjuvant radiotherapy in pathologic T3N0 rectal cancer using a DeepSurv-based survival model

  • by Yunxia Huang, Yanzong Lin, Qingyang Zhuang, Xinyuan Wu, Qiping Fan, Junxin Wu

  • June 12, 2026

Related Content

The unheard pain: why patient-related barriers remain the weakest link in cancer pain management

Origins of CD8 tissue resident memory

Case Report: Granular cell tumor of the axillary tail mimicking node-positive breast carcinoma — two cases with imaging–pathology correlation